Teijin Pharma To Start Oxygen Enricher Home Rental Service
This article was originally published in PharmAsia News
Tokyo based Teijin Pharma will offer an oxygen enricher rental service targeting patients requiring oxygen therapy at home. Circulating as many as three liters of oxygen per minute, Hisanso 3R is also able to automatically humidify enriched oxygen, and thus allows patients to use the device themselves. The device also cuts electricity consumption by 40 percent because it adjusts its speed according to oxygen density. Launched this month, Teijin estimates 8,500 such devices will be ordered by the end of 2009. (Click here for more - Japanese language
You may also be interested in...
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Development Partners International, CDC Group and the European Bank for Reconstruction and Development have collaborated to create a “first of its kind, pan-African” generics platform built on the acquisition and combination of Egypt’s Adwia Pharmaceuticals and India’s Celon Laboratories. An initial $250m investment is to be followed by up to $500m in further funding.
Market Brief: Tissue-Engineered Wound Care Market Expected To Reach $1.9BN By 2024 Amid Rising Chronic Disease
The skin replacement market is led by three key players who have all been impacted by COVID-19, but the sector may see a quicker rebound than others as treatments cannot be deferred for a long time.